IRCT20111105008013N5
Completed
Phase 2
Double-blind placebo-controled clinical trial of Boswellia serrata extract in the treatment of atopic eczema
Ahvaz Jundishapur University of Medical Sciences, medicinal plants research center0 sites66 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences, medicinal plants research center
- Enrollment
- 66
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Atopic ezema
- •Not pregnancy
- •Non lactation
- •Not using oral and topical medication for treatment
Exclusion Criteria
- •Occurrence of local infection
- •Occurrence to other skin diseases
- •Drug sensitivity
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluation of the effect of Ivermectin in treatment of outpatients with COVID-19IRCT20111224008507N4Mazandaran University of Medical Sciences1,000
Recruiting
Phase 3
Evaluation of the effect of Ivermectin in treatment of patients admitted with COVID-19COVID-19 infection.COVID-19, virus identifiedU07.1IRCT20111224008507N5Mazandaran University of Medical Sciences1,000
Recruiting
Phase 2
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitisJPRN-jRCT2031200236Kawai Toshinao8
Recruiting
Not Applicable
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitisChronic granulomatous disease associated colitisJPRN-UMIN000029324ational Center for Child Heath and Development8
Completed
Phase 2
Frankincense effect on urinary disorders in multiple sclerosisMultiple sclerosis.Demyelinating diseases of the central nervous systemIRCT2015071023144N1Ahvaz Jundishapur University of Medical Sciences68